Cellular senescence is a state of irreversible cell growth arrest that occurs when cells experience potentially oncogenic stress.^[@bib1]^ In addition, senescence can be stimulated by diverse factors, such as telomere dysfunction and oxidative damage, as well as the DNA damage response caused by ionising radiation and several chemotherapeutic drugs.^[@bib2]^ Senescence is considered a tumour-suppressive program that halts the proliferation of damaged cells. However, senescent cells remain metabolically active and undergo a plethora of changes in protein expression and the secretion of cytokines and other factors involved in the senescence-associated secretory phenotype (SASP).^[@bib3]^ It is well established that SASP is associated with the development of a pro-oncogenic environment.^[@bib4]^ In the 1920s, Otto Warburg discovered that cancer cells convert glucose to lactate via a high rate of glycolysis despite oxygen availability. This phenomenon of aerobic glycolysis is known as the 'Warburg effect\'.^[@bib5]^ Today, aerobic glycolysis is considered a hallmark of cancer.^[@bib6]^ Excess lactate produced by aerobic glycolysis is released into tumour microenvironment, conferring advantages of tumour survival and growth.^[@bib7]^ In numerous tumour types, glycolysis genes are overexpressed, leading to altered cancer metabolism.^[@bib8],\ [@bib9],\ [@bib10]^ Although the Warburg effect is a well-studied phenomenon, its interplay with senescence is largely unclear.

The protein 5′-adenosine monophosphate-activated protein kinase (AMPK) is Ser/Thr protein kinase that is a crucial sensor of energy status that has an important role in the cellular response to metabolic stress.^[@bib11]^ During periods of energetic stress, AMPK is activated in response to an increased AMP/ATP ratio and inhibits cell proliferation.^[@bib12],\ [@bib13]^ In addition to the AMP/ATP ratio, AMPK can also be activated in response to DNA-damaging agents, such as etoposide, doxorubicin and ionising radiation.^[@bib14],\ [@bib15]^ Several oncogenic mutations and signalling pathways can suppress AMPK signalling, which uncouples the fuel signals from the growth signals and allow tumour cells to divide under abnormal nutrient conditions. This uncoupling permits tumour cells to respond to inappropriate growth signalling pathways that are activated by oncogenes and the loss of tumour suppressors.^[@bib11]^

The nuclear factor kappa B (NF-*κ*B) transcription factors control the expression of genes involved in many critical physiological responses, including the immune and acute phase inflammatory response, cell adhesion, differentiation, oxidative stress responses and apoptosis. Immunity and tumourigenesis also involve a rapid rate of cell division. These conditions demand substantial bioenergetic and biosynthetic requirements, which the cells meet by increasing glucose metabolism.^[@bib16]^ The activation of NF-*κ*B signalling enhances the rate of aerobic glycolysis and upregulates glucose transporter 3. In addition, glycolysis drives NF-*κ*B activation, thus forming a positive-feedback loop.^[@bib17]^

In this study, we investigated the metabolic alterations associated with radiation-induced senescence. We found that the rate of glycolysis was enhanced in the senescent cells through the AMPK and NF-*κ*B signalling pathways. These metabolic alterations were required for radiation-induced senescence. In addition, the alteration also acted as bystander signalling to promote the invasion of non-irradiated, surrounding cells. Our results provide a novel view of cancer metabolism during radiation-induced senescence.

Results
=======

Radiation induces senescence through the enhancement of glycolysis
------------------------------------------------------------------

Although cellular senescence is a state of growth arrest, senescent cells are metabolically active.^[@bib3]^ To gain further insight into the regulation of senescence, a proteomic study using two-dimensional (2D) gel electrophoresis was conducted. According to our previous studies,^[@bib18],\ [@bib19]^ radiation induces senescence in securin-knockdown MDA-MB-231-2A human breast cancer cells but has no effect in parental MDA-MB-231 cells ([Figure 1a](#fig1){ref-type="fig"}). Securin gene knockdown may switch radiation-induced apoptosis to growth arrest and senescence, and thus only minimal apoptosis is observed in irradiated MDA-MB-231-2A cells.^[@bib18],\ [@bib19]^ Therefore, MDA-MB-231-2A cells could potentially serve as a suitable model for cellular senescence. For proteomic study, MDA-MB-231-2A cells were irradiated and then allowed to recover for 4 h. Cell lysates were resolved by 2D gel electrophoresis ([Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}). Among the 69 protein spots that displayed twofold differences, 10 protein spots (designated by arrows in [Supplementary Figure S1A](#sup1){ref-type="supplementary-material"}) were selected for further mass spectrometric analyses ([Table 1](#tbl1){ref-type="table"}). The mRNA expression of these identified proteins was not altered after 4 h of post-irradiation time ([Supplementary Figure S1B](#sup1){ref-type="supplementary-material"}), suggesting that the expression may be altered immediately after irradiation. Interestingly, the energy-producing enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH), involved in glycolysis, was upregulated ([Table 1](#tbl1){ref-type="table"}). This finding was further validated by western blot analysis ([Figure 1b](#fig1){ref-type="fig"}, upper part) and GAPDH enzymatic activity assay ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). In contrast, radiation did not alter the expression level of GAPDH in parental MDA-MB-231 cells ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). GAPDH has long been recognised as an important enzyme in ATP production through the anaerobic glycolysis of a monosaccharide (generally glucose) to pyruvate in the cytosol.^[@bib20]^ Therefore, we hypothesise that glycolysis is enhanced in radiation-induced senescent cells.

Lactate dehydrogenase A (LDHA) catalyses the conversion of pyruvate to lactate in cancer cells.^[@bib21]^ Tyrosine phosphorylation of LDHA enhances its enzyme activity.^[@bib22]^ Radiation induces transient phosphorylation of LDHA and an increase of LDH enzymatic activity in MDA-MB-231-2A cells ([Figure 1b](#fig1){ref-type="fig"}, lower part, and [Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}). However, only residual induction of LDHA phosphorylation was observed in MDA-MB-231 cells ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). Consistently, the rate of glycolysis was enhanced in irradiated MDA-MB-231-2A cells, as indicated by increased extracellular lactate and decreased cell culture medium pH ([Figures 1c and d](#fig1){ref-type="fig"}). To exclude the possibility that radiation-induced metabolic alterations were resulted from the genetic manipulation of MDA-MB-231-2A cells, another human breast cancer cells with low-securin expression (MCF-7) were used. Our previous study has shown that the securin expression level in MCF-7 cells is lower than that in MDA-MB-231 cells (also shown in [Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}), and radiation also induces senescence in MCF-7 cells.^[@bib19]^ Consistent with the results in MDA-MB-231-2A cells, radiation also increased the extracellular level of lactate ([Supplementary Figure S4B](#sup1){ref-type="supplementary-material"}).

To investigate whether enhanced glycolysis is involved in radiation-induced senescence, MDA-MB-231-2A cells were treated with the glycolytic inhibitor dichloroacetate (DCA) before irradiation. DCA is an inhibitor of pyruvate dehydrogenase kinase (PDK). Inhibition of PDK shifts pyruvate metabolism from glycolysis and lactate production to glucose oxidation in the mitochondria.^[@bib23]^ Radiation-induced senescence was inhibited by DCA ([Figure 1e](#fig1){ref-type="fig"}), suggesting that enhanced glycolysis promotes radiation-induced senescence.

AMPK is required for radiation-induced glycolytic enhancement and senescence
----------------------------------------------------------------------------

AMPK, an energy sensor monitoring the cellular energy status, has been reported to regulate metabolism and survival in response to ionising radiation.^[@bib11],\ [@bib24]^ To study the role of AMPK in radiation-induced senescence, the activity of AMPK in irradiated MDA-MB-231-2A and MCF-7 cells was examined via analysis of Thr-172 phosphorylation. As shown in [Figure 2a](#fig2){ref-type="fig"} and [Supplementary Figure S4C](#sup1){ref-type="supplementary-material"}, radiation induced sustained AMPK phosphorylation. Compound C is a reversible and ATP-competitive inhibitor of AMPK.^[@bib25]^ Radiation-induced AMPK phosphorylation was inhibited by compound C ([Figure 2b](#fig2){ref-type="fig"} and [Supplementary Figure S4D](#sup1){ref-type="supplementary-material"}). In addition, compound C inhibited radiation-induced senescence, LDH enzymatic activity and lactate release ([Figures 2c--e](#fig2){ref-type="fig"}). These results suggest that radiation activates AMPK to enhance glycolysis and induce senescence.

Radiation induces monocarboxylate transporter 1 expression through the AMPK/glycolysis pathway
----------------------------------------------------------------------------------------------

Monocarboxylate transporters (MCTs) function as proton symporters and are stereoselective for L-lactate.^[@bib26]^ To investigate whether the MCT upregulation is responsible for the release of lactate, MCT1 expression was examined because it is the most ubiquitous MCT.^[@bib27]^ Radiation induced MCT1 expression in MDA-MB-231-2A cells ([Figure 3a](#fig3){ref-type="fig"}), and the increase was inhibited by compound C although compound C alone induced MCT1 expression ([Figure 3b](#fig3){ref-type="fig"}, left part and [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). To confirm these results, immunofluorescence staining was performed. As shown in [Figure 3c](#fig3){ref-type="fig"}, MCT1 protein expression (green fluorescence) localised to the membrane and cytoplasm was induced after irradiation. Consistently, compound C inhibited radiation-induced MCT1 expression ([Figure 3c](#fig3){ref-type="fig"}). These results suggest that radiation induces MCT1 expression through the activation of AMPK. Interestingly, the inhibition of glycolysis by DCA also reduced radiation-induced MCT1 expression ([Figure 3b](#fig3){ref-type="fig"}, right part and [Figure 3c](#fig3){ref-type="fig"}), suggesting that the enhanced glycolysis also promotes MCT1 expression, which is potentially required for the accelerated exportation of intracellular lactate.

Radiation induces glycolytic enhancement and MCT1 expression through the AMPK/NF-*κ*B pathway
---------------------------------------------------------------------------------------------

Glycolysis activates NF-*κ*B signalling, and p53 restricts NF-*κ*B activity through the suppression of glycolysis. In addition, the activation of NF-*κ*B enhances glycolysis, thus forming a positive-feedback loop.^[@bib17]^ Because p53 is mutated in MDA-MB-231 cells,^[@bib28]^ radiation-induced glycolytic enhancement may further increase NF-*κ*B activity. Indeed, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (I*κ*B-*α*) and NF-*κ*B were phosphorylated in MDA-MB-231-2A cells ([Figure 4a](#fig4){ref-type="fig"}), suggesting that NF-*κ*B signalling is activated by radiation. In contrast, radiation slightly upregulated NF-*κ*B activity in MCF-7 cells ([Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}) that carries wild-type p53.^[@bib28]^ Radiation-induced NF-*κ*B activation was dependent on AMPK as the I*κ*B-*α* and NF-*κ*B phosphorylation in response to radiation was attenuated by compound C in both MDA-MB-231-2A and MCF-7 cells ([Figure 4b](#fig4){ref-type="fig"} and [Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}). However, inhibition of glycolysis by DCA augmented radiation-induced NF-*κ*B activation ([Figure 4c](#fig4){ref-type="fig"}), suggesting that NF-*κ*B may signal upstream of glycolysis and therefore compensate for the inhibition of glycolysis. To investigate whether NF-*κ*B activation was required for radiation-induced glycolytic enhancement, the NF-*κ*B inhibitor BMS-345541 was used to inhibit radiation-induced NF-*κ*B and I*κ*B-*α* phosphorylation ([Figure 4d](#fig4){ref-type="fig"}). NF-*κ*B inhibition decreased the radiation-induced LDH activation, lactate release and MCT1 expression in MDA-MB-231-2A cells ([Figures 4e and f](#fig4){ref-type="fig"}, and [Supplementary Figure S7](#sup1){ref-type="supplementary-material"}). Therefore, these results indicate that radiation induces the AMPK and NF-*κ*B signalling pathways, leading to the enhancement of glycolysis and MCT1 expression.

Radiation promotes the invasion of non-irradiated cells through AMPK- and NF-*κ*B-dependent bystander signalling pathways
-------------------------------------------------------------------------------------------------------------------------

It is well established that radiation induces damage in cells that are not directly irradiated in a phenomenon called the non-targeted bystander effect.^[@bib29]^ Our previous study showed that senescent MDA-MB-231-2A cells promote the invasion of non-irradiated cells.^[@bib19]^ In this study, the invasive behaviour of the non-irradiated MDA-MB-231 cells was also enhanced after treatment with the conditioned medium (CM) from the irradiated MDA-MB-231-2A cells ([Figure 5a](#fig5){ref-type="fig"}). Interestingly, CM induced AMPK activation in the non-irradiated MDA-MB-231 cells ([Figure 5b](#fig5){ref-type="fig"}). AMPK inhibition by compound C attenuated CM-induced invasion of the non-irradiated MDA-MB-231 cells as well as human umbilical vein endothelial cells (HUVECs) ([Figure 5c](#fig5){ref-type="fig"}). In addition, DCA also inhibited CM-induced invasion of the non-irradiated MDA-MB-231 cells and HUVECs ([Figure 5d](#fig5){ref-type="fig"}). Furthermore, CM induced NF-*κ*B activation in the non-irradiated MDA-MB-231 cells and HUVECs, and NF-*κ*B activity inhibition by BMS-345541 attenuated cell invasion ([Figures 6a and b](#fig6){ref-type="fig"}). These results suggest that radiation promotes the invasion of the non-irradiated, surrounding cells through AMPK- and NF-*κ*B-dependent bystander signalling pathways.

Discussion
==========

Although metabolic deregulation has been linked to cancer^[@bib8],\ [@bib9],\ [@bib10]^ and senescence cells are thought to remain metabolically active,^[@bib3]^ the relationship between cellular metabolism and senescence remains unclear. Our previous studies have shown that ionising radiation induces senescence in the securin-knockdown MDA-MB-231-2A and low-securin-expressing MCF-7 human breast cancer cells, but parental MDA-MB-231 cells are not affected. In addition, only minimal apoptosis is induced in irradiated MDA-MB-231-2A and MCF-7 cells.^[@bib18],\ [@bib19]^ These findings support that MDA-MB-231-2A cells serve as a suitable cellular model for investigating the relationship between senescence and metabolism alternation without the disturbance of cell death. In this study, we found that metabolic alterations occur in senescent MDA-MB-231-2A cells, including the enhancement of glycolysis, accelerated release of lactate and sustained activation of AMPK. Interestingly, these metabolic alterations were also detected in non-irradiated, surrounding cells and promoted their invasiveness. Therefore, changes in metabolism are crucial for both radiation-induced senescence and the bystander effect.

The direct role of securin in cellular senescence is current unclear. It has been reported that overexpression of securin activates DNA damage pathway to induce senescence in normal human fibroblasts.^[@bib30]^ In contrast, we and others^[@bib31]^ have shown that securin attenuates drug- and radiation-induced senescence in human colorectal and breast cancer cells. These findings suggest a controversial role of securin in cellular senescence. Possibly, securin *per se* seems not to be a prerequisite for senescence. Securin is involved in controlling the metaphase--anaphase transition and anaphase onset, and fine-tuning of its expression is required for normal cell cycle progression.^[@bib32]^ Inhibition or overexpression of securin blocks sister chromatid separation and results in cell cycle dysregulation.^[@bib32]^ Therefore, the downstream events, such as DNA damage responses and cell cycle arrest, may be more important to induce cellular senescence.

Using proteomic approach, we hypothesise that increased GAPDH expression has a role in radiation-induced glycolytic enhancement. However, the role of GAPDH expression in radiation-induced senescence remains unclear. In addition to its essential role in glycolysis, GAPDH is also a key mediator of many oxidative stress responses through its nuclear translocation and regulation of cell fate.^[@bib33]^ In addition, nuclear translocation of GAPDH also stimulates autophagy by inducing the autophagy protein Atg12.^[@bib34]^ The elevation in glycolysis and enhanced autophagy by GAPDH cooperate to protect cells from caspase-independent cell death.^[@bib34]^ Because autophagy has been reported to facilitate senescence, and activation of AMPK is known to stimulate GAPDH nuclear translocation,^[@bib35]^ we propose that radiation upregulates GAPDH expression to enhance glycolysis and promote autophagy, leading to senescence. However, it has also been reported that S-nitrosylation of GAPDH elicited by nitric oxide augments its binding to Siah1 (an E3 ubiquitin ligase), then promoting nuclear translocation of GAPDH and triggering apoptosis.^[@bib36]^ Apoptosis induced by GAPDH-Siah1 cascade is independent of glycolytic impairment because S-nitrosylation of GAPDH also abrogates its catalytic activity.^[@bib36]^ Our results found that GAPDH enzymatic activity was reduced after 24 h of post-irradiation time ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}), which raises the possibility that GAPDH-Siah1 cascade may act as a negative feedback mechanism to impair GAPDH activity.

Our results indicated that the enhancement of glycolysis was associated with radiation-induced senescence, indicating increased energy demands during senescence. At the cellular level, AMPK senses increases in the AMP to ATP ratio and then phosphorylates substrates to enhance energy production and reduce energy-consuming processes.^[@bib37]^ For example, AMPK phosphorylates and inhibits acetyl-CoA carboxylase that consumes ATP and produces malonyl-CoA for fatty acid synthesis. In addition, AMPK-mediated phosphorylation of ULK-1 triggers autophagy that recycles cellular components for energy production.^[@bib38],\ [@bib39]^ Sustained AMPK activation was observed during radiation-induced senescence. In addition, AMPK is required for radiation-induced glycolytic enhancement and senescence. Consistently, AMP/ATP ratios and AMPK activity increases during cellular senescence in fibroblasts.^[@bib40]^ A recent report also demonstrates significant increase in AMPK phosphorylation in H~2~O~2~-induced senescent cells.^[@bib41]^ Therefore, AMPK could be a general activator of cellular senescence.

The movement of lactate in and out of the cell requires a membrane-bound MCT, such as MCT1.^[@bib26]^ In this study, we found that radiation induced MCT1 expression in the securin-depleted MDA-MB-231-2A cells, potentially leading to lactate efflux. Studies have shown that excess lactate acidifies the tumour microenvironment, leading to cancer cell invasion.^[@bib42]^ MCT1 is also the main facilitator of lactate uptake in cancer and endothelial cells.^[@bib43]^ After entering cells, lactate can trigger the phosphorylation/degradation of I*κ*B-*α* and subsequently stimulate the NF-*κ*B pathway.^[@bib44]^ Our results indicate that CM induced NF-*κ*B activation in the non-irradiated cancer cells and HUVECs, possibly due to lactate uptake.

It is well known that senescent cells exhibit pro-tumourigenic effects on neighbouring cells through the secretion of cytokines and factors involved in the SASP.^[@bib4]^ Recently, SASP factors, including TGF-*β* family ligands, VEGF, CCL2 (MCP-1) and CCL20 (MIP-3*α*), were shown to mediate paracrine senescence.^[@bib45]^ Our previous study also demonstrated that the senescent MDA-MB-231-2A cells release VEGF, MCP-1 and MIP-3*α*.^[@bib19]^ In this study, we observed metabolic alterations not only in irradiated senescent cells but also in neighbouring cells, which may also occur in a paracrine manner through these SASP factors. Whether paracrine senescence was induced in neighbouring cells requires future investigation.

In conclusion, our results revealed a correlation between metabolism and senescence in human breast cancer cells. Radiation induced the activation of metabolic pathways such as AMPK/NF-*κ*B and glycolysis in the securin-depleted MDA-MB-231-2A cells, which are involved in radiation-induced senescence. In addition, a radiation-induced bystander effect appears to be induced by similar alterations in metabolic signalling pathways. Therefore, metabolic alterations are coupled to both senescence and a bystander effect in response to radiation.

Materials and Methods
=====================

Chemicals and antibodies
------------------------

Sodium DCA, compound C and BMS-345541 were purchased from Sigma Chemical (St. Louis, MO, USA). The anti-phospho-LDHA (Tyr-10), anti-LDHA, anti-phospho-AMPK (Thr-172), anti-AMPK, anti-phospho-NF-*κ*B p65 (Ser-468), anti-NF-*κ*B, anti-phospho-I*κ*B-*α* (Ser-32) anti-I*κ*B-*α* and antibodies were purchased from Cell Signaling Technology, Inc. (Beverly, MA, USA). The anti-MCT1 was purchased from Merck Millipore (Temecula, CA, USA). The anti-actin and GAPDH antibodies were purchased from Chemicon International (Temecula, CA, USA).

Cell culture
------------

The MDA-MB-231 and human securin shRNA-transfected MDA-MB-231-2A human breast cancer cell lines were kindly provided by Dr. Ji-Hshiung Chen (Department of Molecular Biology and Human Genetics, Tzu Chi University, Taiwan). The cells were grown in DMEM medium (Gibco, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin, 100 *μ*g/ml streptomycin and 1 mM sodium pyruvate solution. The MDA-MB-231-2A cells were selected using DMEM containing 0.5 mg/ml puromycin dihydrochloride. HUVECs purchased from ScienCell Research Laboratories (Carlsbad, CA, USA), were grown in endothelial cell medium supplemented with 5% FBS, 100 units/ml penicillin and 100 *μ*g/ml streptomycin. The cells were cultured at 37 °C and 5% CO~2~ in a humidified incubator (310/Thermo, Forma Scientific, Inc., Marietta, OH, USA).

X-ray irradiation
-----------------

Radiation was generated using an X-ray machine (RS2000; RAD Source Technologies, Coral Springs, FL, USA) operating at 160 kVp (peak kilovoltage) and 25 mA. The cells were replenished with fresh medium and immediately subjected to X-ray irradiation. A 6-Gy radiation dosage was chosen for this study on the basis of our previous study.^[@bib19]^

Senescence-associated *β*-galactosidase staining
------------------------------------------------

Senescent cells were analysed using a *β*-gal staining kit (Cell Signaling Technology) in accordance with the manufacturer\'s instructions. The percentage of senescence-associated *β*-galactosidase-positive cells was calculated by counting the cells in 10 random fields (at least 100 cells) using bright-field microscopy at a magnification of × 40. The experiments were performed in triplicate.

Western blot analyses
---------------------

Cellular protein extracts were collected as described previously.^[@bib46]^ In brief, equivalent amounts of proteins were subjected to electrophoresis using 10% sodium dodecyl sulfate-polyacrylamide gels. After the electrophoretic transfer of proteins onto polyvinylidene difluoride membranes, the membranes were sequentially hybridised with primary antibody followed by a horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). The protein bands were visualised using the enhanced chemiluminescence detection system (Immobilon Western Chemiluminescent HRP Substrate, WBKLS0500, Millipore, Bedford, MA, USA). The gel-digitising software Un-Scan-It gel (Version 5.1; Silk Scientific, Inc., Orem, UT, USA) was used to quantify the relative intensity of the bands on the X-ray films.

Immunofluorescence staining and confocal microscopy
---------------------------------------------------

To view MCT1 protein expression, the cells were subjected to immunofluorescence staining and confocal microscopy as described.^[@bib46]^ At the end of the treatment, the cells were fixed with 4% paraformaldehyde solution in phosphate-buffered saline (PBS) overnight at 4 °C. Thereafter, the cells were washed three times with PBS, and the non-specific binding sites were blocked with PBS containing 10% FBS and 0.3% Triton X-100 for 1 h. The cells were incubated overnight at 4 °C with the rabbit anti-MCT1 (1:100) in PBS containing 10% FBS. Subsequently, the cells were incubated with the anti-rabbit-conjugated FITC antibody (1 : 50) in PBS for 2--3 h at 37 °C. Finally, the nuclei were stained with 2.5 *μ*g/ml Hoechst 33258 for 30 min at room temperature. The samples were examined using a Olympus confocal laser scanning microscope (FluoView FV10i, Olympus, Tokyo, Japan).

Extracellular lactate measurement
---------------------------------

For this study, 3 × 10^5^ cells were plated in 35 mm dishes for 24 h, following different experimental treatments. CM from two independent experiments was collected and assayed using a lactate assay kit (BioVision, Milpitas, CA, USA) following the manufacturer\'s instructions.

pH measurement
--------------

For this study, 3 × 10^5^ cells were seeded in 35 mm dishes for 24 h. CM was collected from plates. The results represent two independent experiments, and pH was measured using a pH metre at approximately 25 °C (Denver Instrument UltraBasic).

GAPDH enzymatic activity assay
------------------------------

Protein extracts were used in the GAPDH assay using a colorimetric assay kit (ScienCell Research Laboratories) according to the manufacturer\'s protocol. This method is based on the oxidisation of *β*-NADH to *β*-NAD in the presence of 3-phosphoglyceric acid (3-PGA), adenosine 5′-triphosphate (ATP) and GAPDH. The GAPDH activity is determined by assaying the rate of NADH oxidation, which is proportional to the reduction in absorbance at 340 nm over time. In brief, 5 *μ*l of each sample or standard was transferred to the 96-well plate containing 145 *μ*l of GAPDH assay mixture in each well and then mixed immediately. The absorbance at 340 nm was recorded over a 12 min interval. Enzymatic activity was calculated as units/ml according to the absorbance of GAPDH standard.

LDH enzymatic activity assay
----------------------------

The LDH activity assay in cell lysates was measured by a colorimetric assay kit (BioVision, Mountain View, CA, USA). In this assay, LDH reduced NAD to NADH, which then interacts with a specific probe to produce colour (absorbance at 450 nm). In brief, cells were lysed in ice-cold assay buffer. Five microlitres of each sample or standard was mixed with 50 *μ*l of Reaction Mix. The absorbance at 450 nm was recorded over a 30-min interval. Enzymatic activity was calculated as nmol/ml according to the absorbance of NADH standard.

Conditioned media
-----------------

MDA-MB-231-2A cells were grown in DMEM for 24 h. The culture media was replaced with fresh medium, and the cells were exposed to 6 Gy radiation. The media was collected 12 h after radiation and contained increased lactate levels compared with control. The time point of 12 h post radiation was chosen to exclude the possibility that an increased number of cells could affect the lactate concentration. Subsequently, the collected media was centrifuged at 2000 r.p.m. for 5 min at 4 °C to remove the cells and cell debris.

Boyden chamber assay
--------------------

An invasion assay was performed using gelatine (Sigma)-coated membranes (pore size, 8 mm; BD Biosciences, San Jose, CA, USA). The membrane was soaked in 0.5 M acetic acid for 24 h to enlarge the pores; subsequently, the membrane was rinsed twice with double deionised water then being soaked in 100 mg/ml gelatine for 16 h. Approximately 8 × 10^3^ cells were suspended in 1% (MDA-MB-231) and 5% (HUVECs) serum medium and plated in the top chamber (Neuro Probe, Inc., Cabin John, MD, USA). Medium supplemented with 10% serum DMEM or 2A-CM was used as a chemoattractant in the lower chamber. After incubation for 16 h, the cells remaining on the bottom side of the membrane were stained with Giemsa (Merck, Darmstadt, Germany), imaged and counted.

Statistical analyses
--------------------

All data represented the mean±S.E. of at least three independent experiments. Statistical analyses were performed using one-way analyses of variance, and additional *post hoc* testing was performed using the statistical software GraphPad Prism 4 (GraphPad Software, Inc. San Diego, CA, USA). A *P* value \<0.05 was considered significant.
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![Radiation enhances senescence and glycolysis in securin-knockdown MDA-MB-231-2A cells. (**a**) Left: Total extracts of MDA-MB-231 and MDA-MB-231-2A cells were prepared for western blot analyses. Right: both cells were exposed to 6 Gy radiation. After 5 days of recovery, cellular senescence was examined by senescence-associated *β*-galactosidase (SA-*β*-gal) staining. Senescent cells (blue staining) were observed by bright-field microscopy. (**b**--**d**) MDA-MB-231-2A cells were exposed to 6 Gy radiation followed by various recovery periods. The protein expression was examined by western blot analyses (**b**). The lactate concentration (**c**) and pH (**d**) of the culture medium were examined by protocols described in the Materials and Methods section. \**P*\<0.05 or \*\**P*\<0.01 indicates significant differences between control and irradiated cells. ^\#\#^*P*\<0.01 indicates significant differences compared with time zero. (**e**) MDA-MB-231-2A cells were pretreated with 5 or 10 mM DCA for 2 h and then exposed to 6 Gy radiation. After 2 days of recovery, cellular senescence was examined by SA-*β*-gal staining. Senescent cells (blue staining) were observed by bright-field microscopy, and the percentage of SA-*β*-gal-positive cells was quantified. \*\**P*\<0.01 indicates significant differences between control and irradiated cells. ^\#\#^*P*\<0.01 indicates significant differences between inhibitor-treated and untreated cells](cddis2014220f1){#fig1}

![Radiation induced AMPK-dependent senescence and glycolytic enhancement in securin-knockdown MDA-MB-231-2A cells. (**a**) MDA-MB-231-2A cells were exposed to 6 Gy radiation followed by various recovery periods. The protein expression was examined by western blot analyses. (**b**) MDA-MB-231-2A cells were pretreated with 5--20 *μ*M compound C for 2 h and then exposed to 6 Gy radiation. The protein expression was examined by western blot analyses after an 8-h recovery period. (**c**) MDA-MB-231-2A cells were pretreated with 5 or 10 *μ*M compound C for 2 h and then exposed to 6 Gy radiation. After 2 days of recovery, cellular senescence was examined by senescence-associated *β*-galactosidase (SA-*β*-gal) staining. Senescent cells (blue staining) were observed by bright-field microscopy, and the percentage of SA-*β*-gal-positive cells was quantified. \*\**P*\<0.01 indicates significant differences between control and irradiated cells. ^\#\#^*P*\<0.01 indicate significant differences between inhibitor-treated and untreated cells. (**d**) MDA-MB-231-2A cells were pretreated with 5 or 20 *μ*M compound C for 2 h, and then exposed to 6 Gy radiation. After a 24-h recovery period, the LDH enzymatic activity was examined by protocols described in the Materials and Methods section. \*\**P*\<0.01 indicates significant differences between control and irradiated cells. ^\#\#^*P*\<0.01 indicates significant differences between inhibitor-treated and untreated cells. (**e**) MDA-MB-231-2A cells were pretreated with 10 *μ*M compound C for 2 h, and then exposed to 6 Gy radiation. After a 24-h recovery period, the lactate concentration in the culture medium was examined by protocols described in the Materials and Methods section. \*\**P*\<0.01 indicates significant differences between control and irradiated cells. ^\#\#^*P*\<0.01 indicates significant differences between inhibitor-treated and untreated cells](cddis2014220f2){#fig2}

![Radiation induced MCT1 expression through AMPK/glycolysis-dependent pathways in securin-knockdown MDA-MB-231-2A cells. (**a**) MDA-MB-231-2A cells were exposed to 6 Gy radiation followed by various periods of recovery. The protein expression was examined by western blot analyses. (**b**) MDA-MB-231-2A cells were pretreated with 5--20 *μ*M compound C (left part) or 5--20 mM DCA (right part) for 2 h and then exposed to 6 Gy radiation. After an 8-h recovery period, the protein expression was examined by western blot analyses. (**c**) MDA-MB-231-2A cells were pretreated with 10 *μ*M compound C or 10 mM DCA for 2 h and then exposed to 6 Gy radiation. After a 12-h recovery period, MCT1 protein expression was examined by fluorescent microscopy analysis. MCT1 displayed green fluorescence using the anti-rabbit-conjugated FITC antibody. The nuclei were stained with Hoechst 33258](cddis2014220f3){#fig3}

![The role of NF-*κ*B in radiation-induced metabolic alterations in securin-knockdown MDA-MB-231-2A cells. (**a**) MDA-MB-231-2A cells were exposed to 6 Gy radiation followed by various recovery periods. The protein expression was examined by western blot analyses. (**b**--**d**) MDA-MB-231-2A cells were pretreated with 5--20 *μ*M compound C (**b**), 5--20 mM DCA (**c**) or 1--10 *μ*M BMS-345511 (**d**) for 2 h and then exposed to 6 Gy radiation. After an 8-h recovery period, the protein expression was examined by western blot analyses. (**e**) MDA-MB-231-2A cells were pretreated with 5 or 10 *μ*M BMS-345511 for 2 h and then exposed to 6 Gy radiation. After a 24-h recovery period, the lactate concentration in the culture medium was examined by protocols described in the Materials and Methods section. \*\**P*\<0.01 indicates significant differences between control and irradiated cells. ^\#\#^*P*\<0.01 indicates significant differences between inhibitor-treated and untreated cells. (**f**) MDA-MB-231-2A cells were pretreated with 1--10 *μ*M BMS-345511 for 2 h, and then exposed to 6 Gy radiation. After an 8-h recovery period, the protein expression was examined by western blot analyses](cddis2014220f4){#fig4}

![Radiation induced a bystander effect through AMPK/glycolysis-dependent pathways. (**a**) MDA-MB-231-2A cells were exposed to 6 Gy radiation followed by various recovery periods. The conditioned media (2A-CM) was collected and used to treat MDA-MB-231 cells. Serum-free and complete medium (10% FBS) were used as negative and positive controls, respectively. After 16 h, cell invasion was examined using the Boyden chamber assay. The numbers of invading cells were observed by microscopy and quantified. \*\**P*\<0.01 indicates significant differences between 2A-CM- and 10% FBS-treated cells. (**b**) MDA-MB-231 cells were treated with 2A-CM for various time intervals. The protein expression was examined by western blot analyses. (**c** and **d**) MDA-MB-231 cells or HUVECs were pretreated with compound C (**c**) or DCA (**d**) for 2 h and then exposed to 2A-CM for 16 h. Cell invasion was examined using the Boyden chamber assay. The number of invading cells was quantified. \*\**P*\<0.01 indicates significant differences between 2A-CM- and 10% FBS-treated cells. ^\#\#^*P*\<0.01 indicates significant differences between inhibitor-treated and untreated cells](cddis2014220f5){#fig5}

![Radiation induced a bystander effect through NF-*κ*B-dependent pathways. (**a**) MDA-MB-231 cells were pretreated with BMS-345541 for 2 h, and then exposed to 2A-CM for 4 h. The protein expression was examined by western blot analyses. (**b**) MDA-MB-231 cells or HUVECs were pretreated with BMS-345541 for 2 h and then exposed to 2A-CM for 16 h. Cell invasion was examined using the Boyden chamber assay. The number of invading cells was quantified. \*\**P*\<0.01 indicates significant differences between 2A-CM- and 10% FBS-treated cells. ^\#\#^*P*\<0.01 indicates significant differences between inhibitor-treated and untreated cells](cddis2014220f6){#fig6}

###### Proteomics data, ranked by fold change for 10 differentially expressed (at least twofold) characterised protein between control and IR

  **Spot number**   **Fold change**   **Protein name/NCBI accession/gene name (Homo sapiens)**                                                                                       **Function**
  ----------------- ----------------- ---------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------
  3207              +9.8              Proteasome activator complex subunit 3 isoform 2, NCBI accession no. 30410796, *PSME3*                                                         Peptide cleavage
  7201              +6.63             Glyceraldehyde-3-phosphate dehydrogenase, NCBI accession no. 31645, *GAPDH*                                                                    Metabolism
  7409              +4.64             26S Protease regulatory subunit 8 isoform 2, NCBI accession no. 312596881, *PSMC5*                                                             Peptide cleavage
  2608              +4.45             Copine-1 isoform a, NCBI accession no. 23397696, *CPNE1*                                                                                       Membrane trafficking
  7508              +4.06             Adenylyl cyclase-associated protein 1, NCBI accession no. 5453595, *CAP1*                                                                      Metabolism/motility
  2811              +3.65             Heat-shock protein 105 kDa, NCBI accession no. 42544159, *HSPH1*                                                                               Protein folding
  1216              +3.28             Chain A, the effect of metal binding on the structure of annexin V and implications for membrane binding, NCBI accession no. 809185, *ANXA5*   Membrane trafficking
  2805              +3.13             Transitional endoplasmic reticulum ATPase, NCBI accession no. 6005942, *VCP*                                                                   Transport/Protein degradation
  4417              −23.92            Adenosylhomocysteinase isoform 1, NCBI accession no. 9951915, *AHCY*                                                                           Methylation
  5414              −30.59            26S Proteasome subunit 9, NCBI accession no. 2150046, *PSMD9*                                                                                  Peptide cleavage

[^1]: These authors contributed equally to this work.
